Glycyl-L-leucine peptide ligand was complexed with different transition metals. These metal complexes were investigated using the physicochemical techniques mentioned in the experimental part.
The elemental analyses
The elemental analyses show a satisfactory agreement between the experimental, and theoretical results. All complexes were formed in a stoichiometric ratio (1:1) (Metal: Ligand). The analytical results are concisely presented in Table 1.
The results of the elemental analysis revealed that:
Cu(Gly-Leu) has one coordinated water molecule in its chemical structure.
Ni(Gly-Leu) has two water molecules (hydrated and coordinated) in its chemical structure.
Cd (Gly-Leu) has one coordinated water molecule in its chemical structure.
Table1. Analytical and physical data of metal (Gly-Leu) complexes.
|
Compound (empirical formula)
|
Color
|
Yield %
|
Found (Calc.) %
|
|
C
|
H
|
N
|
|
[Cu(Gly-Leu)( H2O)]
C8H16CuN2O4
|
Brown
|
70.0
|
34.99 (35.88)
|
5.30 (6.02)
|
10.01 (10.46)
|
|
[Ni(Gly-Leu)(H2O)] .H2O
C8H18N2NiO5
|
Green
|
82.0
|
33.79 (34.20)
|
6.20 (6.46)
|
9.42 (9.97)
|
|
[Cd(Gly-Leu)( H2O)]
C8H16CdN2O4
|
White
|
90.0
|
29.99 (30.35)
|
4.40 (5.09)
|
8.56 (8.85)
|
Infrared analysis
The infrared spectra are, as expected, Interestingly, they exhibit considerable similarity in the spectral ranges where the vibrational bands of the coordinating groups appear. These vibration positions are compared in Table 2, and the proposed assignment is based on several references (13-15). The interpretation of spectra is based on the comparison between the chelated peptide with its free form. These assignments were pointed out as:
- After coordination, a clear shift to higher wavenumbers values was observed for the amino NH2 groups stretching vibrations with some broadening related to the coordinated or hydrated water molecules stretching vibrations.
- After coordination, the disappearance of the N–H stretching of the amido moiety, because of the deprotonation of this group.
- After coordination, there was a noticeable shift in the carbonyl group (C=O) stretch within the amide linkage towards lower energy levels, which aligns with its participation in the bonding.
- After coordination, the stretching vibrations of the two carboxylate groups underwent minimal alterations, a characteristic typically associated with bridging carboxylate groups (16).
- Within all the complexes, the coordination environment is completed by the inclusion of water molecules. This is substantiated by the detection of OH bending vibrations from the water molecules that are coordinated(5).
- The bands assigned to metal-ligand vibrations are tabulated in Table 2 (5, 17)
Table 2. The most important IR frequencies bands of complexes (200- 4000 cm−1).
|
Compound
|
υ(NH2)
|
υ (COO- ) as
|
υ (M-O)
|
υ (M-N)
|
|
Cu-(Gly-Leu)
|
3410
|
1558,1442
|
447, 401
|
331,308
|
|
Ni-(Gly-Leu)
|
3410
|
1581, 1504
|
493, 416
|
339,308
|
|
Cd-(Gly-Leu)
|
3410
|
1558, 1512
|
450,408
|
345,321
|
1HNMR analysis
The 1HNMR spectra of the free peptide and its Cd (II) complex as a representative example from the synthesized complexes were screened in DMSO-d6 against TMS as internal reference is obtained.
For ligand: 1HNMR gave the aliphatic protons at 0.84, 0.89, 1.4, and 3.7 for (CH3) groups, (CH)A, (CH2)B, and (CH2)C respectively. NH2 (amino), NH (amide) and OH protons are given as sharp singlet peaks at 3.3, 4.2, and 8.2 ppm respectively (D2O exchangeable). After coordination, all (A, B & C) and NH2(amino) signals were shifted to lower values with the absence of the protons corresponding to each NH(amide) and OH carboxylate group. The suggested structures are seen in Figure 1.
Molar conductance and magnetic susceptibility studies
Conductivity measurements indicate that values below 50 Ώ -1 ohm-1cm2 in DMSO solution are for nonelectrolytes (18). The low molar conductance readings of the synthesized complexes suggest their non-electrolytic nature. This observation corroborates the complexes’ coordination with the carboxylate anion and the subsequent ionization of the amide proton ( C=NH ), resulting in the full neutralization of the metal’s cationic charge. These findings are in line with prior elemental analysis, (IR), and (1H NMR) studies.
We have two observations about the values of our Cu(II) magnetic moment (1.81 B.M.): First, the value is present in the values registered for the hexa-coordinate Cu(II)complex (19). Second, the measured value is slightly more than the registered value for one unpaired electron (1.73 B.M.) (spin-only value). So, it suggested mainly distorted octahedral geometry(20).
The magnetic moment reading of our Ni(II) chelate was 3.40 BM. It presents within the octahedral geometry structure range of 2.8-3.5 BM for Ni(II) complexes (21). For the Cd (II) complex, the magnetic moment has a diamagnetic nature. It corresponds to octahedral geometry due to its electronic configuration (d10).
Thermal study
Thermogravimetric analysis, which tracks weight changes, was performed for synthesized complexes using the TG technique. This analysis spanned from ambient temperature up to 800°C. The primary purpose of these methods is to deduce details about the water molecules’ existence and their location—whether they are part of the inner or outer coordination sphere surrounding the central metal ion. Additionally, these procedures assess the thermal stability of the complexes. The data regarding the percentage of mass loss are detailed in Table 3. The initial stage of weight loss corresponds to the water molecules that are either directly bonded to the metal ions or incorporated within the crystal lattice (5). As represented in Figure 2, all complexes showed the evaporation of one water molecule at a temperature of more than 200oC corresponding to the coordinated water molecule. The values of their weight loss % are 6.20, 6.02, and 6.0 for Cu-(Gly-Leu), Ni-(GlyLeu) and Cd-(Gly-Leu) complexes respectively. Ni-chelate only showed evaporation for one hydrated water molecule at a temperature equal to 100 oC. Upon additional heating, the complexes display a decline in mass, which is attributed to the decomposition of the organic components. Cu (II), Ni (II) and Cd (II) complexes showed the breaking of the organic ligand in one step with the mass loss [Cu 4.45 %( 63.58%)], [Ni 65.7% (56.0%)] and [Cd 53.89% (53.76%)] for the experimental and the calculated values respectively. In conclusion, the segment of the thermogram that aligns with the x-axis (indicative of temperature) represents the remaining residue. It was anticipated that this residue would constitute metal oxide for every type of complex analyzed. The metal residue percentages are [Cu 29.29 %( 29.68%), Ni 24.30 %( 24.98%) and Cd 40.11 %( 40.55%)] for the experimental and the calculated values respectively. It was observed that Cu-(Gly-Leu) chelate has higher stability because it decomposed at a higher temperature than the other chelates. Finally, from all previous studies, we can deduce that the coordination is carried out through the N2O2 arrangement of ligand atoms. The coordination sites were completed with a carbonyl oxygen atom and a water molecule. The complexes showed polymeric structures using bridging carboxylate groups.
Table 3. The thermal decompositions of metal complexes.
|
Compound
|
DTG, Experimental (Calculated)
|
|
[Cu(Gly-Leu)( H2O)]
|
Coordinated water = 6.2% (6.7%)
Organic compound =64.45% (63.58%)
Residue CuO= 29.29% (29.68%)
|
|
[Ni(Gly-Leu)( H2O )].H2O
|
Hydrated water + Coordinated water = 12.5% (12.04%)
Organic compound =65.7% (65.0%)
Residue NiO= 24.3% (24.98%)
|
|
[Cd(Gly-Leu)( H2O)]
|
Coordinated water = 6.0% (5.6%)
Organic compound =53.89% (53.76%)
Residue CdO= 40.11% (40.55%)
|
Antibacterial investigation
Antimicrobial peptides are potent agents with diverse structural and antimicrobial peptides, which represent one of the hopeful future drugs for combating infections and microbial drug resistance. So, the following work represents the bacterial investigation of the (Gly-Leu) peptide ligand and its modified compounds by its chelation with Copper (II), Cadmium (II), and Nickel (II) metal ions. Water culture is discussed in the experimental part revealing the presence of Gram-negative (Enterobacteriaceae group). Enterobacteriaceae are Gram-negative bacteria of a large family that includes Escherichia coli, Klebsiella, Salmonella, Shigella, Yersinia pestis8 (22) and Gram-negative (fecal coliform). Klebsiella pneumonia . and Escherichia coli hurt humans as Klebsiella pneumonia is a considerable pulmonary pathogen leading to severe pneumonia and sepsis, mainly in immunocompromised patients. Escherichia coli is the major common reason for acute urinary tract infections as well as urinary tract sepsis. Escherichia coli is a usual cause of ‘traveler's diarrhea, a dysentery-like disease affecting humans and may raise acute enteritis in humans as well as animals (23) so the antibacterial investigation was done against Klebsiella and Escherichia Coli strains. Also, it performed against the Enterobacteriaceae group as a whole. The investigation involved the inhibition zone technique by measuring the diameters of inhibition zone values presented in Figures 3(a, b) and Table 4. The antibacterial effect of the peptide ligand appeared after its coordination with the metal ions. Cd(II) and Ni(II) complexes were found to possess significant antibacterial activity against Klebsiella pneumonia and Escherichia coli bacteria respectively when compared to the standard drug (Gentamicin). Cu-chelate showed moderate activity against the Enterobacter organism. Klebsiella pneumonia effectively died by using Cu-chelate rather than the standard Gentamicin drug. The metal complexes exhibited greater antimicrobial properties compared to their ligands This enhanced activity is likely due to the structural alterations that occur upon coordination. Within these complexes, the polarity of the metal ions is diminished as a result of the partial sharing of the negative charge from the heterocyclic ligands. Consequently, this reduction in polarity augments the lipophilicity of the metal ions, enabling them to more effectively infiltrate and traverse the lipid membranes of microorganisms, leading to their destruction. additionally, the activity index is shown in Fig.4(a)(17). In addition, the antimicrobial activity of Cu-complex was significantly greater than others, which may be mostly because of the relatively strong lipophilic property and its higher stability as mentioned before in the thermal study. The results revealed that the antibacterial assay against gram-negative bacteria was effective. It may be due to the composition of the gram-negative bacteria having a thin peptidoglycan layer that facilitates the penetration of the compound into the bacteria and kills it. MIC was performed for the best zone of inhibition results, Fig. 4(b). It was tested for Cd(II) and Cu(II) chelates
against Klebsiella pneumonia organism but Ni-chelate against Escherichia coli. The MIC values were tabulated in Table 5. The Cu-chelate demonstrated strong activity against Klebsiella, with a MIC value of 62.5 μg/ml, comparable to that of the standard drug gentamicin, whereas the Cd-complex showed a moderate effect (MIC=125 μg/ml) equal to the double effect of Cu and gentamicin compounds. By comparing MIC values of gentamicin and Ni-complex against Escherichia coli, Ni complex showed a mild effect (31.25μg/ml).
Table 4. Zone inhibition (mm.) of (Gly-Leu) ligand and its chelates.

Table 5. Minimum Inhibitory Concentration (MIC) of (Gly-Leu) ligand and its chelates.

Molecular Docking Investigation:
Molecular docking plays an important essential role in the rational design of drugs. Molecular docking can be described as the “best-fit” orientation of a ligand that binds to a certain protein of interest (24, 25). Antimicrobial peptides (AMPs), as emerging therapeutic agents, offer a strategy to counteract the development of pathogens. Therefore, our objective is to develop a potential AMP that can control bacterial growth by focusing on various targets, allowing us to forecast and analyze its antibacterial impact.
Killing bacteria may be done in different ways.
One of these ways is perhaps due to the inhibition of bacterial cell wall synthesis. We can target penicillin-binding proteins (PBP) and glucosamine-6-phosphate enzymes as key examples involved in bacterial cell wall synthesis. (PBP) plays a pivotal role in the synthesis of the bacterial cell wall, primarily through its transglycosylation and transpeptidation activities (26, 27). It’s a recognized fact that alterations in PBP can result in the emergence of strains of pathogenic bacteria that are resistant to antibiotics (28). The altered version of the penicillin-binding protein 5’s crystal structure was sourced from the Protein Data Bank, under the identifier 1NJ4. This variant of PBP5’s structure was ascertained through X-ray crystallography and documented with a resolution of 1.9 Ångströms (29). Furthermore, the resistance of bacteria to Gly-Leu compounds was investigated through molecular docking studies with the altered PBP5.
Interaction analyses of our compounds are seen in Table 6 and Figure S1-S4. S1-S4 showed that the Cu-chelate forms a high interaction with the mutated version of PBP5, exhibiting a binding energy of −9.3 kcal/mol. This strong bond is facilitated by three hydrogen bonds, each less than 3 Ångströms in length, with the mtPBP5. Hydrogen bonds were found between Asp113 with (amino position) of cu-chelate of 1.81 Å bond length and (Asp105 & Asn112) with coordinated water molecules of (2.02 & 1.82) Å bond lengths respectively. Cu-chelate showed side chain acceptor and backbone donor types of interactions towards the selected protein with a higher number than the other investigated compounds.
The computational forecast aligns closely with the outcomes of antibacterial tests, as demonstrated in the subsequent section on antibacterial analysis. This correlation underscores the considerable influence of molecular docking research.
Glucosamine-6-phosphate (GlcN-6-P) was synthesized from d-l-glutamine and fructose-6-phosphate by using the glucosamine-6-phosphate synthase enzyme. Synthesis of UDP-N-acetylglucosamine (UDP-GlcNAc) depends initially on (GlcN-6-P). UDP-GlcNAc is present in all types of organisms (30). The GlcN-6-P synthase inactivation time has a different effect between the microbes and the human cells. GlcN-6-P disappearance in bacteria is fatal for microbes but vice versa in mammals (31). So, Glucosamine-6-phosphate (GlcN-6-P) synthase is a compelling target for protein interaction studies due to its critical function in safeguarding the cell walls of a wide range of microorganisms and human cells alike (32).
Consequently, a substantial body of research on molecular docking targeting GlcN-6-P synthase has been conducted, emphasizing its role as a key enzyme in the development of antibacterial agents. (33, 34). The potential inhibitor is expected to bind with the enzyme’s active site, resulting in the formation of a complex between the ligand and the enzyme. This complex is a key element in the mechanism that leads to inhibition. (35).
The process of docking synthesized molecules with enzymes demonstrated that the expected inhibitor compounds exhibited hydrogen bonding interactions with multiple amino acid residues within the active pockets of GlcN-6-P synthase, as illustrated in Figures S5-S8. In the chemical structure of the synthesized compounds, it was observed that the Gly-Leu ligand interacts with Met-89 at a distance of (3.0 Ǻ). Gly-Leu ligand forms interactions through the (NH2) amino, carbonyl oxygen (COOH) and (NH) amide oxygen atoms with Val567, Pro521 and Asp548 active moieties of enzyme respectively. All three synthesized chelates form hydrogen bonds with Asp474 and Ser316 residues. Glu569 active amino acid was observed in both Cd and Ni chelates. Furthermore, based on the molecular docking prediction in Table 7. The three chelates exhibited high performance against the target enzyme as supported by their lower binding energies (-6.7, -6.25 and -6.16 kcal mol-1) for Ni-, Cd- and Cu- chelates respectively) with comparing to Gly-Leu peptide as the Previous studies indicated that a low binding energy is necessary for enzyme inhibition, as reported by various research works (36). The activation energy of the inhibition reaction prefers the more negative binding energy which leads to tight binding of the enzyme-inhibitor complex (35). The backbone acceptor type of interaction was the most widespread type with all molecules against the selected protein.
Another way for killing bacteria is perhaps due to inhibition of bacterial DNA replication, transcription, repair, and recombination by targeting DNA gyrase enzymes as examples.
DNA gyrase enzyme is required for bacterial DNA replication, transcription, repair, and recombination. the target is to evaluate the possible relationship between the docking activity of the synthesized compounds with the crystal structure of the DNA-gyrase receptor (PDB Code: 5BS8). The results of molecular docking were investigated (Table 8) based on energy score. Cu-chelate was docked with a better binding energy score of -18.1 kcal/mol in comparison to other synthesized compounds. So, Cu-chelate showed a higher antibacterial potency. The results were compatible with the previous antimicrobial assay. The hydrogen bonding was found to be the prominent interaction of amino groups with DNA-gyrase Figures. S9-S12. The amino acid residues interacted are ArgA39, Asp-B536, Asp-B534, and GluB459 with side chain donor, Metal contact, side chain acceptor, and side chain donor interaction types respectively.
Finally, we found docking DNA gyrase and penicillin-binding protein enzymes results were in good agreement with the experimental results that revealed that Cu-chelate is the best one as an antibacterial drug.
Table 6. Molecular Docking Results with Mutant PBP5 (mtPBP5) (PDB Code: 1nj4)
|
|
Docking 1nj4
|
|
|
Compounds
|
Involved amino acids
|
Type of interaction
|
Scoring Energy
(kcal/mol) (RMSD)
|
|
Gly-Leu
|
Met-89 (3.0 Å)
|
Backbone acceptor
|
-4.139(0.99)
|
|
Cu-(Gly-Leu)
|
Asp-113 and Asp-105
Asn-112
|
Side chain acceptor backbone donor
|
-9.373(1.85)
|
|
Cd-(Gly-Leu)
|
Gln-195 (2.09 Å),
(2.14 Å)
|
Side chain acceptor and side chain donor
|
-3.148(2.49)
|
|
Ni-(Gly-Leu)
|
Ligand exposure
|
Ligand exposure
|
-5.049(2.48)
|
Table 7. Molecular docking parameters towards GlcN-6-P synthase (PDB Code: 1moq)
|
|
docking 1moq
|
|
|
Compound
|
Involved amino acids
|
Type of interaction
|
Scoring Energy
(kcal/mol) (RMSD)
|
|
Gly-Leu
|
Val-567
Pro-521 (2.85 Ǻ)
Asp-548
|
Backbone acceptor
Backbone acceptor
Side chain acceptor
|
-2.7(1.03)
|
|
Cu-(Gly-Leu)
|
Asp-474 (1.69 Ǻ)
Ser-316(2.29 Ǻ)
|
Side chain acceptor
Side chain acceptor
|
-6.16(2.90)
|
|
Cd-(Gly-Leu)
|
Glu-569 (2.15 Ǻ)
Asp-474 (2.44 Ǻ)
Ser-316 (3.0 Ǻ)
|
Side chain acceptor
Side chain acceptor
Side chain donor
|
-6.25(1.80)
|
|
Ni-(Gly-Leu)
|
Glu-569 (2.6 Ǻ)
Asp-474 (2.01 Ǻ)
Ser-316 (2.99 Ǻ)
|
Metal contact
Side chain acceptor
Side chain donor
|
-6.7(3.20)
|
Table 8. Binding affinity of complexes against DNA-gyrase receptor (PDB Code: 5BS8)
|
Antitumor docking 5BS8
|
|
|
Compound
|
Involved amino acids
|
Type of interaction
|
Scoring Energy
(kcal/mol) (RMSD)
|
|
Gly-Leu
|
Gln-C113 (2.32 Ǻ)
Ser-C69 (3 Ǻ)
Asp-A157 (2.86)
His-C70 (2.43)
|
side-chain donor
side-chain donor
side-chain acceptor
backbone acceptor
|
-3.88(0.841)
|
|
Cu-(Gly-Leu)
|
Arg-A39 (2.02 Ǻ) (2.077 Ǻ)
Asp-B536
Asp-B534 (2.05 Ǻ)
Glu-B459 (2.05 Ǻ)
|
side-chain donor
Metal contact
side-chain acceptor
side-chain acceptor
|
-18.13(2.11)
|
|
Cd-(Gly-Leu)
|
Arg-C128 (2.21 Ǻ)
Ser-A91 (3.0 Ǻ)
His-A87 (1.81 Ǻ)
|
side chain donor
side-chain donor
backbone acceptor
|
-6.649(1.89
|
|
Ni-(Gly-Leu)
|
Gly-A88 (1.96 Ǻ)
Asp-B532 (2.1 Ǻ)
Glu-B459 (2.01 Ǻ),(2.25 Ǻ)
|
side-chain donor
side-chain acceptor
side-chain acceptor
|
-10.88(2.77)
|
Antioxidant Activity
The attack of reactive species such as free radicals on cellular structures leads to the onset of numerous diseases associated with oxidative damage. In the last decades, antioxidants become important because of the high exposure to free radical pollution (37). Newly, the investigation and seeking for metal-derived antioxidants become very interesting to identify new compounds having a high capacity in scavenging free radical pollution. Due to synthetic antioxidants being more effective and cheaper than natural antioxidants, they become widely used. Consequently, a specific criterion exists for evaluating the antioxidant activity of metal complexes.
DPPH (1,1-diphenyl-2-picrylhydrazyl) is a stable nitrogen radical and a widely known free radical used in vitro for testing antioxidant activity. It has an odd electron and exhibits a strong absorption band at 517 nm. When this electron is paired off, the absorption decreases stoichiometrically relative to the number of electrons accepted(38). Due to the variation in absorbance readings, DPPH has been extensively used to assess the ability of different substances to act as free radical scavengers. On the other hand, DPPH also is decolorized by reducing agents as well as H transfer, which also contributes to inaccurate interpretations of antioxidant capacity. So, DPPH is usually used as a suitable material to evaluate the antioxidant activity of other antioxidants. We employed ascorbic acid (commonly known as Vitamin C) as our reference standard.
We evaluated the antioxidant activity of both the free peptide (Glycyl-L-leucine) and its three metal chelates [Cu(II), Cd(II), & Ni(II)], alongside ascorbic acid serving as the standard reference drug. This assessment was based on their ability to scavenge stable DPPH free radicals. Additionally, IC50 values were calculated to determine the potency of the tested samples, representing the concentration required to reduce a specific activity by half. The variations in the free radical scavenging efficacy of the test compounds, expressed as percent inhibition, are depicted in Figure 5. From these data, it is clear that most of the chelates showed excellent antioxidant activity than the parent ligand, especially Ni(II) and Cu(II) chelates. Both complexes have IC50 are very near to the IC50 value of the standard (ascorbic acid). The IC 50 values are (14.4, 15.5, 18, 44.9 and 78) for (Vit. C, Ni, Cu, peptide and Cd) respectively. The increased antioxidant potency observed in the metal complexes compared to the original ligand might stem from the electron-withdrawing influence of the metals, which hastens hydrogen removal to counteract DPPH. Notably, our compounds contain numerous proton sources. Consequently, hydrogen atoms are susceptible to abstraction by free radicals, leading to the formation of stable radicals. This is evidenced by the transition of the solution from purple to yellow, indicating the scavenging of DPPH radicals through hydrogen donation (38).
Antiviral Molecular Docking:
In this paragraph, we asked if our AMP-derived compounds can serve as anti-viral drugs against the COVID-19 virus. Focusing on the main protease (PDB id: 6LU7) is becoming increasingly crucial in the development of anti-CoV medications. The Protein-ligand interaction of the stable docked AMPs-based compounds with the main protease complex was visualized in Figure 6. All AMPs based compounds showed hydrogen bond interactions with the active amino acids mentioned in Table 9 as Gln-C113, Ser-C69, Asp-A157, His-C70, Arg-A39, Asp-B534, Glu-B459, Arg-C128, Ser-A91, His-A87, Gly-A88 and Asp-B532. According to the lower scoring energy value, Cu-chelate provides the more successfully docked interactions. Cu-chelate molecular docking proved that the better antibacterial drug was the better antiviral one also. But finally, we can’t say that, in general, the antibacterial drug should help as an antiviral drug.
Table 9. Binding affinity of complexes with main protease (6LU7).
|
docking 6LU7
|
|
|
Compound
|
Involved amino acids
|
Type of interaction
|
Scoring Energy
(kcal/mol) (RMSD)
|
|
Gly-Leu
|
Gln-C113 (2.32 Ǻ), Ser-C69 (3.0 Ǻ)
Asp-A157 (2.86 Ǻ)
His-C70 (2.43 Ǻ)
|
Side chain donor
Side chain acceptor
Backbone acceptor
|
-2.46(1.28)
|
|
Cu-(Gly-Leu)
|
Arg-A39 (2.02 Ǻ) (2.077 Ǻ)
Asp-B536
Asp-B534 (2.05 Ǻ), Glu-B459 (2.05 Ǻ)
|
Side chain donor
Metal contact
Side chain acceptor
|
-9.22(2.49)
|
|
Cd-(Gly-Leu)
|
Arg-C128 (2.21 Ǻ), Ser-A91 (3.0 Ǻ)
His-A87 (1.81 Ǻ)
|
Side chain donor
Backbone acceptor
|
-5.85(1.82)
|
|
Ni-(Gly-Leu)
|
Gly-A88 (1.96 Ǻ)
Asp-B532 (2.1 Ǻ), Glu-B459 (2.01 Ǻ)
|
Side chain donor
Side chain acceptor
|
-7.67(1.51)
|